1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS

GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS

  • December 2016
  • 146 pages
  • ID: 2354690

Summary

Table of Contents

Use this report to:
• Analyze each market and its application, regulatory environment, technologies involved, new products and advancements, market projections and market shares.
• Focus on the global bioengineered protein drug market and its products to measure the areas of market growth in bioengineered protein drugs, products, manufacturers, and users.
• Provide an overview of the current and future characteristics of the global market for bioengineered protein drugs to understand broad spectrum of medicines to treat various diseases and with newer technologies in various arenas of biomedical research.
• Discuss relevant patent analysis and comprehensive profiles of companies that lead to the bioengineered protein drugs industry.

Highlights
• The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021 from $172.5 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.8% from 2016 through 2021.
• The United states region of bioengineered protein drugs market is the largest market. The market is expected to grow from $93.7 billion in 2016 to $148.7 billion in 2021 at a CAGR of 9.7% for the period 2016-2021.
• The Emerging markets for bioengineered protein drugs is expected to grow from $39.8 billion in 2016 to $40.2 billion in 2021 at a CAGR of 0.2% for the period 2016-2021.

STUDY GOALS AND OBJECTIVES
Bioengineered protein drugs play a noticeable role in the biopharmaceutical industry. These drugs offer a broad spectrum of medicines to treat various diseases and with newer technologies, the market is expanding dynamically.

BCC Research’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for bioengineered protein drugs. The key objective is to present a comprehensive analysis and future direction of bioengineered protein drugs as a treatment option for various diseases and disorders.

This report explores present and future strategies within the bioengineered protein drugs market, which includes categories such as peptide hormones, monoclonal antibodies, cytokines, therapeutic enzymes, blood products, vaccines and peptide antibiotics. The improvisation of the market, the setbacks and the needs are discussed in this report, as well as the classifications, comparisons and usage of these types of drugs.

A detailed analysis of the bioengineered protein drug industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for a five-year period from 2016 through 2021.

Market by diseases for bioengineered protein drugs is also discussed separately in the report, with emphasis of the usage of these type drugs in various disease sectors. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY
Bioengineered protein drugs are widely used as therapeutic drugs due to their high potency and reduced side effects. Growth in this market is expected due to extensive research and innovations in the field of drug discovery.

In addition, the frequency of chronic diseases and the increase of cancer rates are driving market expansion. In recent years, manufacturing companies of all sizes have begun to focus on the production of protein drugs.

R&D spending, along with increasing competition, patent expiries and new technologies are directing this market. New advancements, new product launches and changing lifestyles will influence market growth for the foreseeable future. This study looks at almost all the systems affected by these factors.

Acquisition strategies and collaborations between companies are also covered in this report, as well as the strength and weaknesses of each type of protein drug category in light of the new technologies, growing competition, and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study contributes to the areas of market growth in bioengineered protein drugs, products, manufacturers, and users. Genomic research centers, academic institutions, government and private laboratories, hospitals, as well as pharmaceutical, diagnostic and biotechnology companies, and physicians will find this study to be of interest.

SCOPE OF THE STUDY Bioengineered protein drugs are drugs that help treat chronic diseases like diabetes, asthma, cancer, various blood disorders, fertility disorders, immunological disorders and hormonal disorders.

This report focuses on the global bioengineered protein drug market and its products, and provides an updated review of its applications in various arenas of biomedical research.
The scope of the study is global.

BCC Research analyzes each market and its application, regulatory environment, technologies involved, new products and advancements, market projections and market shares. The technological issues include all the latest trends, pipeline products and developments.

The bioengineered protein drugs that are covered in this report are monoclonal antibodies, cytokines, peptide antibiotics, vaccines, therapeutic enzymes, blood factors, and peptide hormones.

These products are all bioengineered and produced by recombinant DNA technology.
The geographical regions covered in the report are North America, Europe, and emerging markets. The emerging market segment covers countries including India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada among others.

Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead to the bioengineered protein drugs industry. Some of the major players of the market include Eli Lilly and Co., AbbVie Inc., F. Hoffmann–La Roche Ltd., Sanofi S.A., Novo Nordisk AG, Novartis AG, Merck & Co., Merck KGaA and Amgen Inc., among others.

METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, among many other sources.

Data were collected through interviews and correspondence with manufacturers and users of bioengineered protein drugs. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES
Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of bioengineered protein drug products. Data were gathered from various industry sources.

BCC Research spoke with officials within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ANALYST’S CREDENTIALS
The study has been carried out by a team of professionals in the biotechnology industry. The project manager is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has over 14 years of industry experience.

She was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
TNF Inhibitors - A Pipeline Analysis Report

TNF Inhibitors - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

TNF Inhibitors: An insightThe TNF inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global TNF inhibitors market. The anti-TNF drugs are among the top 10 global ...

Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast to 2022

Veterinary/Animal Vaccines Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of ...

Antithrombin Market  - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Antithrombin Industry: Forecasts to 2025

  • $ 5795
  • Industry report
  • October 2017
  • by Transparency Market Research

Global Antithrombin Market – OverviewThis report on antithrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.